Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Spires

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Neuropathology and Applied Neurobiology|November 6, 2018
Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's diseaseM Tzioras, C Davies, A Newman, et al.
Science (New York, N.Y.)|July 16, 2005
Tau suppression in a neurodegenerative mouse model improves memory functionK Santacruz, J Lewis, T Spires, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2022
First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743S Peters, A Scherpereel, R Cornelissen, et al.
ESMO Open|February 17, 2026
Fast Real-Time Assessment of Combination Therapies in Immuno-ONcology in patients with advanced non-small-cell lung cancer (FRACTION-Lung)K He, P M Forde, R Govindan, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Neuropathology and Applied Neurobiology|November 6, 2018
Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's diseaseM Tzioras, C Davies, A Newman, et al.
Science (New York, N.Y.)|July 16, 2005
Tau suppression in a neurodegenerative mouse model improves memory functionK Santacruz, J Lewis, T Spires, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2022
First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743S Peters, A Scherpereel, R Cornelissen, et al.
ESMO Open|February 17, 2026
Fast Real-Time Assessment of Combination Therapies in Immuno-ONcology in patients with advanced non-small-cell lung cancer (FRACTION-Lung)K He, P M Forde, R Govindan, et al.
Pageof 1